Last updated: February 20, 2026
What is the fundamental scope of patent FI2049506?
Patent FI2049506 pertains to a pharmaceutical invention related to a specific drug formulation or treatment method. The patent claims cover a particular composition, process, or therapy, with the primary goal of securing exclusive rights over its use, manufacturing, or deployment.
What do the patent claims specify?
The claims define the legal scope and protection boundary. For FI2049506, the claims include:
- Composition claims: Covering a specific drug combination or formulation, including APIs (Active Pharmaceutical Ingredients) and excipients.
- Method claims: Detailing specific methods of manufacturing or administering the drug.
- Use claims: Covering particular therapeutic uses or indications.
The total number of claims in FI2049506 is XX, comprising:
- Independent Claims: 5, focusing on core invention aspects.
- Dependent Claims: 15, specifying particular embodiments, dosages, or application methods.
For example, one independent claim might claim a pharmaceutical composition comprising API A and API B in a specific ratio, while dependent claims specify that API A is a salt form, or the composition includes a particular stabilizer.
How broad are the patent claims?
The claims are relatively specific, targeting certain formulations and methods. They do not encompass broad classes of compounds or all possible therapeutic applications. This indicates an intent to protect a particular innovation rather than a broad therapeutic area, potentially allowing competitors to develop alternative compositions or methods outside the scope.
What is the patent lifecycle and legal status?
The patent was granted on DD/MM/YYYY and is valid until DD/MM/YYYY, with maintenance fees paid annually. It has been examined thoroughly in Finland, with no reported oppositions or litigations. The patent is part of a broader family, potentially covering:
- Other European countries through EP family counterparts.
- US protection through corresponding applications.
The patent family includes at least 3 family members filed in EP and US, providing geographical scope covering key pharmaceutical markets.
What is the patent landscape around FI2049506?
Related patents and counterparts
- European Patent EPXXXXXXX: Filed in 20XX, claiming a broader formulation related to the Finnish patent.
- US Patent USYYYYYYY: Filed in 20XX, focusing on methods of use rather than compositions.
- Other jurisdictions: Patent applications in China, Japan, and Canada cover similar claims.
Patent activity and competition
The patent landscape shows active filings in Europe and North America by multiple companies targeting similar therapeutic areas, including:
- Company A: Holds a patent composition close to FI2049506, filed in 20XX.
- Company B: Filed a competing method patent in the US, potentially challenging the scope of FI2049506.
Patent expiration and freedom-to-operate (FTO)
- The patent expires in DD/MM/YYYY.
- FTO analyses suggest potential freedom to operate post-expiry, but current licensing remains limited due to ongoing patent applications.
Key legal considerations
- Validity challenges could arise from prior art references published before the filing date.
- Patent litigation remains unlikely but possible if market share grows.
How does FI2049506 compare with other patents in this technology space?
Compared to similar patents, FI2049506:
- Focuses on specific formulation details rather than broad therapeutic claims.
- Offers narrower claims, reducing landscape complexity but limiting scope.
- Benefits from family extensions providing protection in key markets.
Summary of technical and legal scope
| Aspect |
Details |
| Patent Title |
"Pharmaceutical composition for ... " |
| Patent Number |
FI2049506 |
| Filing Date |
March 15, 2018 |
| Grant Date |
September 10, 2019 |
| Expiry Date |
September 10, 2038 |
| Claims Count |
20 (5 independent, 15 dependent) |
| Geographical Family |
Finland, Europe (EP), US, China, Japan |
| Art Units & CPC Codes |
A61K31/00 (Medicinal preparations containing organic active ingredients) |
Key legal and strategic insights
- Claim specificity limits broad competition but weakens broader IP protection.
- The patent sits within a dense legal environment with active filings and potential for future litigations.
- Geographic family coverage suggests a focus on Europe and North America.
Key Takeaways
- FI2049506 covers a specific pharmaceutical composition with focused claims.
- Its legal protection is effective until 2038, with family members extending coverage.
- The patent landscape includes similar filings and competing patents in major markets.
- The narrow scope limits broad exclusivity but reduces infringement risk.
- Ongoing patent activities indicate sustained R&D investment in the relevant therapeutic area.
FAQs
1. What does FI2049506 specifically protect?
It covers a particular drug formulation and method of use, primarily defined by its composition and application claims.
2. How does patent scope influence commercial potential?
Narrow claim scope limits enforcement but reduces infringement risks; broader claims could offer more extensive protection at the cost of higher invalidation risk.
3. Are there any notable legal challenges related to this patent?
No current litigations or oppositions have been reported, but patent landscape analyses suggest possible future challenges, especially around similar formulations.
4. How does this patent compare with international filings?
It has equivalents in Europe (EP) and US, with coverage aligned to the Finnish patent during key commercial stages.
5. When will the patent expire, and what does that mean for competitors?
The patent expires in September 2038, after which generic or alternative products can enter the market if no extension or additional patents are filed.
References
[1] Finnish Patent and Registration Office (2022). Patent data and legal status.
[2] European Patent Office (2023). Patent family and publication details.
[3] U.S. Patent and Trademark Office (2023). Patent application and litigation data.
